Erdem, S. Et Al. 2019. A relapsed refractory CD30 positive cutaneous anaplastic large cell lymphoma with large B-cell transformation responding to brentuximab vedotin after multiple lines of treatment.. Xth International Eurasian Hematology Oncology Congress , (İstanbul, Turkey), 560.

Erdem, S., Özbalak, M., Baykal, C., & Kalayoğlu Beşışık, S., (2019). A relapsed refractory CD30 positive cutaneous anaplastic large cell lymphoma with large B-cell transformation responding to brentuximab vedotin after multiple lines of treatment. . Xth International Eurasian Hematology Oncology Congress (pp.560). İstanbul, Turkey

Erdem, Simge Et Al. "A relapsed refractory CD30 positive cutaneous anaplastic large cell lymphoma with large B-cell transformation responding to brentuximab vedotin after multiple lines of treatment.," Xth International Eurasian Hematology Oncology Congress, İstanbul, Turkey, 2019

Erdem, Simge Et Al. "A relapsed refractory CD30 positive cutaneous anaplastic large cell lymphoma with large B-cell transformation responding to brentuximab vedotin after multiple lines of treatment.." Xth International Eurasian Hematology Oncology Congress , İstanbul, Turkey, pp.560, 2019

Erdem, S. Et Al. (2019) . "A relapsed refractory CD30 positive cutaneous anaplastic large cell lymphoma with large B-cell transformation responding to brentuximab vedotin after multiple lines of treatment.." Xth International Eurasian Hematology Oncology Congress , İstanbul, Turkey, p.560.

@conferencepaper{conferencepaper, author={Simge ERDEM Et Al. }, title={A relapsed refractory CD30 positive cutaneous anaplastic large cell lymphoma with large B-cell transformation responding to brentuximab vedotin after multiple lines of treatment.}, congress name={Xth International Eurasian Hematology Oncology Congress}, city={İstanbul}, country={Turkey}, year={2019}, pages={560} }